Cargando…
Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections”
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416810/ https://www.ncbi.nlm.nih.gov/pubmed/37577111 http://dx.doi.org/10.1093/ofid/ofad423 |
_version_ | 1785087865651200000 |
---|---|
author | Srivastava, Shashikant Gumbo, Tawanda |
author_facet | Srivastava, Shashikant Gumbo, Tawanda |
author_sort | Srivastava, Shashikant |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10416810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104168102023-08-12 Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections” Srivastava, Shashikant Gumbo, Tawanda Open Forum Infect Dis Correspondence Oxford University Press 2023-08-07 /pmc/articles/PMC10416810/ /pubmed/37577111 http://dx.doi.org/10.1093/ofid/ofad423 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Correspondence Srivastava, Shashikant Gumbo, Tawanda Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections” |
title | Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections” |
title_full | Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections” |
title_fullStr | Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections” |
title_full_unstemmed | Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections” |
title_short | Comment on “Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections” |
title_sort | comment on “long-term safety and tolerability of omadacycline for the treatment of mycobacterium abscessus infections” |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416810/ https://www.ncbi.nlm.nih.gov/pubmed/37577111 http://dx.doi.org/10.1093/ofid/ofad423 |
work_keys_str_mv | AT srivastavashashikant commentonlongtermsafetyandtolerabilityofomadacyclineforthetreatmentofmycobacteriumabscessusinfections AT gumbotawanda commentonlongtermsafetyandtolerabilityofomadacyclineforthetreatmentofmycobacteriumabscessusinfections |